Ofloxacin is a racemate composed of equal amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent that inhibits bacterial DNA gyrase and topoisomerase IV, thereby halting DNA replication.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 83380-47-6
DL-ofloxacin
pharmaceutical raw material
(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-nitroso-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
pharmaceutical intermediate
Desethylamiodarone
pharmaceutical raw material
Elagolix
pharmaceutical raw material
Voglibose
pharmaceutical raw material
Cyclosporin h
pharmaceutical raw material
Levofloxacin
pharmaceutical raw material
Levofloxacin hemihydrate
pharmaceutical raw material
7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O